Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover Arcutis Biotherapeutics stock have a consensus rating of "Strong Buy" and an average price target of $25, which forecasts a -3.85% decrease in the stock price over the next year. The lowest target is $15 and the highest is $37.

Price Target: $25 (-3.85%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$15	$25	$29	$37
Change	-42.31%	-3.85%	+11.54%	+42.31%

Analyst Ratings

The average analyst rating for Arcutis Biotherapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	4	4	4	4	4	4
Buy	1	1	1	1	1	1
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Serge Belanger Needham	Needham	Strong Buy Maintains $30 → $31	Strong Buy	Maintains	$30 → $31	+19.23%	Jan 26, 2026
Uy Ear Mizuho	Mizuho	Buy Maintains $32 → $37	Buy	Maintains	$32 → $37	+42.31%	Nov 28, 2025
Richard Law Goldman Sachs	Goldman Sachs	Hold Maintains $19 → $29	Hold	Maintains	$19 → $29	+11.54%	Oct 30, 2025
Serge Belanger Needham	Needham	Strong Buy Maintains $22 → $30	Strong Buy	Maintains	$22 → $30	+15.38%	Oct 28, 2025
Serge Belanger Needham	Needham	Strong Buy Maintains $20 → $22	Strong Buy	Maintains	$20 → $22	-15.38%	Aug 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

366.32M

Increased by 86.38%

from 196.54M

Revenue Next Year

477.27M

Increased by 30.29%

from 366.32M

EPS This Year

-0.18

from -1.16

EPS Next Year

0.38

from -0.18

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	3.69M	59.61M	196.54M	366.32M	477.27M
Revenue Growth	-	-	-	1,517.09%	229.74%	86.38%	30.29%
EPS	-3.80	-4.18	-5.66	-3.78	-1.16	-0.18	0.38
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	68.16
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	383.6M	493.6M
Avg	366.3M	477.3M
Low	346.5M	454.7M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	95.2%	34.7%
Avg	86.4%	30.3%
Low	76.3%	24.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-0.15	0.49
Avg	-0.18	0.38
Low	-0.25	0.20

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.